HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
Clinical trial NCT04684914 · TERMINATED
Trial details
- NCT number
- NCT04684914
- Sponsor
- Altimmune, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-26
- Primary completion
- 2024-03-27
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.